The GAVI Alliance Board Have Approved a Framework That Will Support The Immunisation of an Additional 300 Million Children in Developing Countries

Canada Commits C$ 500 Million to Support Immunisation in Developing Countries

New pledge at the Francophonie Summit will help protect millions of children from deadly diseases November 28, 2914 Gavi, the Vaccine Alliance today welcomed the announcement by Canada of a C$ 500 million contribution to support immunisation in developing countries between 2016 and 2020. The new funding will support Gavi’s work to enable the world’s 73 poorest countries to immunise …

The GAVI Alliance Board Have Approved a Framework That Will Support The Immunisation of an Additional 300 Million Children in Developing Countries

5-in-1 vaccine now in all 73 poorest countries

July 30th, 2014 -Introductions target successfully achieved – work still to be done on increasing coverage The five-in-one pentavalent vaccine is being used in all GAVI Alliance-supported countries – now the race is on to increase coverage of the vaccine which protects children against five life-threatening diseases. Pentavalent, which protects against diphtheria, tetanus and pertussis (DTP) as well as hepatitis …

The GAVI Alliance Board Have Approved a Framework That Will Support The Immunisation of an Additional 300 Million Children in Developing Countries

GAVI Alliance Board Approves New 2016-2020 Framework

The GAVI Alliance Board Have Approved a Framework That Will Support The Immunisation of an Additional 300 Million Children in Developing Countries The GAVI Alliance Board, a global health partnership committed to increasing access to immunisation in poor countries, has approved a new framework for 2016-2020 that will support the immunisation of an additional 300 million children from 2016-2020 in developing …

GSK announces new commitment to improve access to vaccines with 5-year price freeze for countries graduating from GAVI Alliance support

May 20, 2014 GSK announced today that it will freeze the prices of its vaccines for five years for developing countries that graduate from GAVI Alliance support. By committing to offer GAVI Alliance prices for vaccines against pneumococcal disease, rotavirus and cervical cancer, GSK will support developing country governments as they transition to financing the full cost of their local …

This is the Future of the Vaccine Industry

  The vaccine business is changing. The vaccine industry is moving at a remarkable pace. And we here at Vaccine Nation have sought out the the leading minds within the vaccines industry to explain the challenges and opportunities we can expect in the future. Our experts from across the vaccines spectrum explain to us the mechanics behind the vaccine industry …

China’s JE vaccine gains GAVI support, enters global marketplace

China has the largest vaccine manufacturing capacity in the world, but has yet to really make its mark in the global vaccine marketplace. While Chinese firms primarily make vaccines the domestic market, an entry into global health could have a significant effect, potentially driving down vaccine prices and accelerating global immunization efforts. Up until October, however, no Chinese-made vaccine had …

GAVI gathers minds to tackle vaccine supply chain issues

"Vaccines are one of the most cost-effective healthcare interventions ever invented, but they can become unusable due to supply chain failures, requiring innovative ways to store and transport them," says GAVI CEO Dr Seth Berkley. No matter how great a vaccine is, it's useless if you can't adequately deliver it to the people that need it. Now GAVI has launched …

World Vaccine Congress & Expo vaccinates African village

The World Vaccine Congress & Expo has recently donated towards the GAVI Campaign, a US Charitable mission that supports immunization programs in developing countries and help protect children in the world’s poorest countries from vaccine-preventable diseases. The GAVI Campaign supports the GAVI Alliance. The World Vaccine Congress & Expo's donation has helped vaccinate a whole village in Southern Ethiopia with …

Rotavirus vaccine for children indirectly protects adults: More cost-effective than previously thought

The paediatric rotavirus vaccination programme that is currently being rolled out by the WHO worldwide may actually be more cost-effective than previously thought, as vaccinating children against rotavirus may indirectly protect unvaccinated adults from the highly contagious disease. Rotavirus is the most common cause of severe diarrhoea in infants worldwide, accounting for over a third of severe diarrhoea cases worldwide. …